Amalgamated Bank’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$200K Sell
10,215
-204
-2% -$4.99K ﹤0.01% 1563
2025
Q4
$279K Sell
10,419
-75
-0.7% -$1.93K ﹤0.01% 1491
2025
Q3
$280K Sell
10,494
-55
-0.5% -$1.42K ﹤0.01% 1482
2025
Q2
$242K Sell
10,549
-212
-2% -$5.26K ﹤0.01% 1504
2025
Q1
$312K Sell
10,761
-237
-2% -$7.57K ﹤0.01% 1417
2024
Q4
$408K Sell
10,998
-278
-2% -$12.7K ﹤0.01% 1364
2024
Q3
$547K Sell
11,276
-205
-2% -$9K ﹤0.01% 1266
2024
Q2
$459K Sell
11,481
-137
-1% -$5.68K ﹤0.01% 1328
2024
Q1
$510K Sell
11,618
-4,726
-29% -$244K ﹤0.01% 1306
2023
Q4
$1.01M Sell
16,344
-578
-3% -$30.4K 0.01% 1167
2023
Q3
$778K Sell
16,922
-357
-2% -$19.5K 0.01% 1216
2023
Q2
$993K Buy
17,279
+58
+0.3% +$2.57K 0.01% 1133
2023
Q1
$646K Sell
17,221
-1,188
-6% -$38.9K 0.01% 1310
2022
Q4
$516K Sell
18,409
-168
-0.9% -$4.88K ﹤0.01% 1449
2022
Q3
$522K Buy
18,577
+371
+2% +$12.1K 0.01% 1413
2022
Q2
$633K Buy
18,206
+1,297
+8% +$46.3K 0.01% 1354
2022
Q1
$607K Sell
16,909
-1,024
-6% -$29K ﹤0.01% 1465
2021
Q4
$418K Buy
17,933
+213
+1% +$4.36K ﹤0.01% 1662
2021
Q3
$337K Sell
17,720
-291
-2% -$5.7K ﹤0.01% 1792
2021
Q2
$363K Buy
+18,011
New +$339K ﹤0.01% 1796

Other funds holding AMPH

Amalgamated Bank's AMPH Position: Q1 2026 in Review

Amalgamated Bank reduced its Amphastar Pharmaceuticals (AMPH) stake by 2% in Q1 2026, selling an estimated $4.99K and leaving 10,215 shares worth $200K. The position accounts for ﹤0.01% of the portfolio, ranked #1563.

Amalgamated Bank first reported a position in AMPH in Q2 2021 and has held it in 20 quarters since. The position peaked at $1.01M in Q4 2023. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.

  • Amalgamated Bank held 10,215 shares of Amphastar Pharmaceuticals worth $200K as of Q1 2026.
  • Amalgamated Bank sold 204 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $4.99K.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Amalgamated Bank's portfolio in Q1 2026, its #1563 holding.
  • Amalgamated Bank first reported a position in Amphastar Pharmaceuticals in Q2 2021 and has held it in 20 quarters since.
  • Amalgamated Bank's Amphastar Pharmaceuticals position peaked at $1.01M in Q4 2023.
  • 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.